China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…
Read More »Hansoh Pharmaceutical Group
Hong Kong stocks fell for a fifth straight session on Wednesday, tracking an overnight sell-off on Wall Street and lingering…
Read More »Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…
Read More »

